Mangrove Partners’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Mangrove Partners’s Portfolio EQHA.WS Stock Details EQHA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-165,994	Closed	-$1.64M	–	436
2022 Q3	$1.64M	Hold	165,994	–	–	0.1%	244
2022 Q2	$1.63M	Hold	165,994	–	–	0.08%	347
2022 Q1	$1.63M	Hold	165,994	–	–	0.09%	330
2021 Q4	$1.61M	Hold	165,994	–	–	0.1%	385
2021 Q3	$1.62M	Sell	165,994 -97,606	-37%	-$61.9K	0.15%	263
2021 Q2	$187K	Buy	263,600 +39,350	+18%	+$22.3K	0.02%	298
2021 Q1	$112K	Buy	+224,250	New	+$130K	0.01%	278

Other funds holding EQHA.WS

Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

Mangrove Partners's EQHA.WS Position: Q4 2022 in Review

Mangrove Partners sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 165,994 shares — an estimated $1.64M sold.

Mangrove Partners first reported a position in EQHA.WS in Q1 2021 and held it in 7 quarters. The position peaked at $1.64M in Q3 2022. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

Mangrove Partners reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
Mangrove Partners sold 165,994 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $1.64M.
Mangrove Partners first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q1 2021 and held it in 7 quarters.
Mangrove Partners's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $1.64M in Q3 2022.
1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Mangrove Partners's 13F filing for Q4 2022, filed 14 Feb 2023.